Published in Virology on February 01, 1981
The sequence of the nucleoprotein gene of human influenza A virus, strain A/NT/60/68. Nucleic Acids Res (1982) 3.99
NS1 protein of influenza A virus down-regulates apoptosis. J Virol (2002) 2.12
Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity. J Virol (1992) 1.74
Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol (1999) 1.61
Formation of influenza virus particles lacking hemagglutinin on the viral envelope. J Virol (1986) 1.30
The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA. J Virol (1998) 0.97
The membrane (M1) protein of influenza virus occurs in two forms and is a phosphoprotein. J Virol (1984) 0.93
Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins. J Mol Genet Med (2009) 0.87
Identification of mumps virus protein and lipid composition by mass spectrometry. Virol J (2016) 0.76
Sequence of the nucleoprotein (NP) gene of the influenza Alanas acuta/Primorje/695/76 (H2N3) virus. Nucleic Acids Res (1991) 0.75
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice. J Virol (2016) 0.75
Viral hijacking of host caspases: an emerging category of pathogen-host interactions. Cell Death Differ (2017) 0.75
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A (1992) 6.85
A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature (1999) 1.67
Influenza virus uncoating in infected cells and effect of rimantadine. J Gen Virol (1982) 1.43
The nucleic acid of Sendai virus and ribonucleic acid synthesis in cells infected by Sendai virus. J Gen Virol (1968) 1.36
Suppression of influenza virus replication in infected mice by protease inhibitors. J Gen Virol (1984) 1.17
Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol (2005) 1.11
Penetration of viral genetic material into host cell. Adv Virus Res (1982) 1.10
Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine. J Gen Virol (1982) 1.02
Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem (1994) 0.97
The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc Natl Acad Sci U S A (1999) 0.95
Nucleoproteins of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells. J Gen Virol (1984) 0.95
A modified plaque assay method for accurate analysis of infectivity of influenza viruses with uncleaved hemagglutinin. Arch Virol (1982) 0.94
Protein synthesis in Sendai virus-infected cells. J Gen Virol (1975) 0.93
Role of gangliosides in reception of influenza virus. Eur J Biochem (1982) 0.93
Myxovirus replication in chicken embryos can be suppressed by aprotinin due to the blockage of viral glycoprotein cleavage. J Gen Virol (1985) 0.92
Cytoplasmic and nuclear input virus RNPs in influenza virus-infected cells. J Gen Virol (1979) 0.91
Infective substructures of Sendai virus from infected Ehrlich ascites tumor cells. J Virol (1968) 0.88
Isolation of Sendai virus RNA from infected cells by the method of thermic fractionation. Biochim Biophys Acta (1966) 0.88
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects. Adv Enzyme Regul (1985) 0.86
Protective effect of protease inhibitors in influenza virus infected animals. Arch Virol (1982) 0.86
High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination. J Med Virol (1987) 0.86
Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells. AIDS Res Hum Retroviruses (1991) 0.85
Proteolytic activation of influenza WSN virus in cultured cells is performed by homologous plasma enzymes. J Gen Virol (1982) 0.85
Additive effect of histones and actinomycin D on the cellular RNA synthesis. Exp Cell Res (1966) 0.84
Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. Antiviral Res (1994) 0.84
Deoxycholate-mediated cleavage of the protein of Sendai virus nucleocapsid derived from infected cells. Biochem Biophys Res Commun (1974) 0.83
Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response. Vaccine (2008) 0.83
[Integration of influenza A virus NSP gene into baculovirus genome and its expression in insect cells]. Vopr Virusol (2010) 0.83
Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents. Antiviral Res (1999) 0.82
Effect of protein synthesis inhibitors on the replication of virus-induced RNA in Sendai virus-infected cells. Acta Virol (1973) 0.81
[Antiviral and therapeutic action of protease inhibitors in viral infections: experimental and clinical observations]. Vopr Virusol (1984) 0.81
Interaction of influenza virus with gangliosides and liposomes containing gangliosides. Eur J Biochem (1988) 0.80
Rimantadine hydrochloride blocks the second step of influenza virus uncoating. Arch Virol (1980) 0.80
Alphavirus replication in cultured cells and infected animals is inhibited by antiproteinase agents. Antiviral Res (1986) 0.78
Properties of intracytoplasmic A particles isolated from oncornavirus-producing human cells. J Virol (1974) 0.78
Intracellular virus-specific structures and RNAs in oncornavirus-producing human cells. J Virol (1974) 0.78
The molecular organization of the influenza virus surface. Studies using photoreactive and fluorescent labeled phospholipid probes. Biochim Biophys Acta (1987) 0.78
Covalent chromatography of influenza virus membrane M1 protein on activated thiopropyl Sepharose-6B. J Chromatogr B Biomed Sci Appl (1998) 0.78
[Interaction of influenza virus matrix protein M1 with histones]. Mol Biol (Mosk) (1997) 0.78
Influenza virus assembly and its defects. Biosystems (1981) 0.77
[Pathogenic effect of pandemic influenza virus H1N1 under replication in cultures of human cells]. Vopr Virusol (2013) 0.77
Fate of Sendai virus ribonucleoprotein in virus-infected cells. J Virol (1969) 0.77
[The phenomenon of proteolytic activation of myxoviruses and a new strategy for treating viral diseases]. Vopr Virusol (1983) 0.77
[Site-directed modification of caspase cleavage site regions in avian influenza virus proteins]. Vopr Virusol (2009) 0.77
[Key role of Asp16 in proteolysis of influenza A NP protein by caspases in infected cells]. Vopr Virusol (2004) 0.77
Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells. Biochem Mol Biol Int (1993) 0.77
[Localization of the influenza virus M1 matrix protein in the virion]. Mol Biol (Mosk) (2000) 0.77
Abortive infection of influenza virus in Ehrlich ascites tumor cells. Unusual fragility of virus particles. Arch Virol (1978) 0.76
[Clinical effectiveness of aprotinin aerosol in influenza and parainfluenza]. Vestn Ross Akad Med Nauk (1996) 0.76
[Enhancement of alphavirus reproduction in cell cultures at an alkaline pH]. Vopr Virusol (1987) 0.76
[Identification of the protease-binding domain in the N-terminal region of the influenza A virus matrix protein M1]. Mol Biol (Mosk) (2001) 0.75
[The pathogenetic therapy of acute respiratory diseases by aprotinin inhalations]. Ter Arkh (1995) 0.75
The participation of sendai virus ribonucleoprotein in virus-specific polysome formation. Virology (1969) 0.75
Replicative forms of Sendai virus RNA. Arch Gesamte Virusforsch (1970) 0.75
Action of histones on replication of myxoviruses. Fed Proc Transl Suppl (1967) 0.75
Influenza virus RNA-synthesizing complex in the nucleoplasm of infected cells. J Gen Virol (1975) 0.75
The intracellular site of RNA synthesis of Newcastle disease virus. Proc Soc Exp Biol Med (1966) 0.75
[Evolutionary changes in the NA and HA genes of H3N2 influenza virus in the Moscow Region during 2003-2009]. Vopr Virusol (2011) 0.75
Matrix proteins of influenza A and B viruses possess common antigenic determinants. Lancet (1985) 0.75
Uncoiling and protein cleavage of paramyxovirus nucleocapsid after incubation with ribosomes in vitro. Biochim Biophys Acta (1973) 0.75
Characteristics of Sendai virus RNA transcriptive complex formed in the cytoplasm of infected ascites cells. Acta Virol (1975) 0.75
Action of influenza virus neuraminidase on gangliosides. Haemagglutinin inhibits viral neuraminidase. FEBS Lett (1985) 0.75
Actinomycin D and histone action in myxovirus reproduction. Lancet (1966) 0.75
[Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction]. Vopr Virusol (2011) 0.75
Biophysical and biochemical properties of type B oncorna viruses isolated from continuous human cell cultures. Mol Biol (1974) 0.75
[Influenza A virus M1 matrix protein is similar to protease inhibitors]. Dokl Akad Nauk (1999) 0.75
Messenger activity of sendai virus ribonucleoprotein in a cell free protein-synthesizing system. Virology (1970) 0.75
[Aprotinin antiviral aerosol: study of the local irritating and allergenic action after inhalation]. Antibiot Khimioter (1995) 0.75
The properties of intracellular paramyxovirus ribonucleoprotein in a nonpermissive system. Arch Gesamte Virusforsch (1974) 0.75
Association of viral ribonucleoprotein with polysomes. Experientia (1969) 0.75
Influenza virus genetic sequences in the blood of children with congenital pathology of the CNS. Arch Virol (1989) 0.75
HIV-1 gag proteins in virions and in infected cell fractions. Biomed Sci (1991) 0.75
Template activity of parainfluenza virus ribonucleoprotein. Nature (1970) 0.75
Physicochemical properties of Sendai virus RNA. II. Effect of ionic strength on thermostability of RNA. Mol Biol (Mosk) (1977) 0.75
[NP gene of pandemic H1N1 virus attenuates virulence of mouse-adapted human influenza virus]. Vopr Virusol (2011) 0.75
[The antiviral aerosol aprotinin. General effect on the body after inhalation administration]. Antibiot Khimioter (1994) 0.75
Formation of proviruses in acute infection in vitro and in vivo. Experientia (1977) 0.75
Enhancement of polysome formation and protein synthesis in Sendai virus-infected cells. J Gen Virol (1976) 0.75
[Surface localization of amino acids in influenza virus hemagglutinin during functional transformation of virions by acidic pH]. Mol Biol (Mosk) (1996) 0.75
[Characterization of proteolytic cleavage of influenza virus nucleocapsid protein NP in infected cells]. Vopr Virusol (2000) 0.75
[pH-dependent rearrangements in the influenza A virus]. Vopr Virusol (2014) 0.75
A comparison of influenza and parainfluenza and RNP properties. Arch Gesamte Virusforsch (1971) 0.75
[Adsorption on synthetic membranes and immunogenic properties of aprotinin cross-linked by glutaraldehyde]. Bioorg Khim (1999) 0.75
Buoyant density of ribosomes of cytoplasmic extracts of mouse and chick cells. Mol Biol (1973) 0.75
Transcriptive functions of Sendai firus nucleocapsid in infected cells. Virology (1973) 0.75
Sedimentation and buoyant density characteristics of influenza virus ribonucleoprotein. Acta Virol (1973) 0.75
Presence of the p27 antigenicity and absence of the gp52 antigenicity and leukemia virus antigens in intracytoplasmic A particles (iAp) of mouse mammary tumour origin. Arch Geschwulstforsch (1976) 0.75
Intracellular localization of recombinant vaccinia virus produced HIV antigens and their use for confirmation of HIV seropositivity. Acta Virol (1990) 0.75
The properties of the Sendai virus ribonucleoproteins involved in genome transcription in infected cells. J Gen Virol (1974) 0.75
Properties of influenzavirus nucleocapsids in nonpermissive cells. Acta Virol (1979) 0.75
[Study of Sendai virus proteins]. Vopr Virusol (1975) 0.75